Zimelidine is effective in the treatment of depression.' Both zimelidine and its pharmacologically active metabolite norzimelidine act by inhibiting the re-uptake of 5-hydroxytriptamine by neurones.2 In comparison with tricyclic antidepressant drugs zimelidine is fairly free of side effects.' We report two cases in which adverse effects developed during a clinical trial of the drug.
normal. Zimelidine was withdrawn. The next day his temperature rose to 38-4'C, but thereafter he remained afebrile. He was treated with paracetamol and oral nystatin only. The headache and photophobia settled over 48 hours.
Hepatic enzyme activities fell steadily and were completely normal one month later. Results of other investigations were normal.
Comment
Both patients were prone to functional illness and had previously complained of headache. In both cases, however, the headache now reported was dramatic in severity and distinctive in character. Though this type of headache and the abnormal liver function may not have been causally linked, the combination of features was so similar that a relation to zimelidine was suggested. Improvement began when the drug was withdrawn, and no other cause could be identified. In both cases results of serological tests for recent viral infection were normal, and hepatitis antibody titres showed only post infection with hepatitis A. Before admission, case 1 had taken Paramol-118 (dihydrocodeine tartrate and paracetamol; Duncan, Flockhart), and case 2 had been taking various analgesics for several months.
Though headache has been reported in connection with zimelidine treatment,3 there are no previous reports of this atypical headache syndrome caused by the drug. The mechanism that produces headaches may be related to a fall in the blood concentration of 5-hydroxytriptamine4 similar to that seen in migraine.5
There is one report of zimelidine causing fever and jaundice in a patient with a history of hepatic reactions to other antidepressant drugs' but no reports of the disturbance in liver function described here.
More than 100 patients have been treated with zimelidine in Glasgow. No During 1981 one person in seven visited an ophthalmic optician,' and one in eight of these was referred to a medical practitioner.2 There is no information on whether the uptake of ophthalmic services is evenly spread within and between practices or on the evenness with which opticians recommend a further opinion. Again there is no detailed information on whether referral forms to general practitioners (OSC 1Z) regularly reach their intended destination or about how they are dealt with when they do. There are ample grounds for believing that the system of referral can irritate all affected by it, whether patients, opticians, general practitioners, or ophthalmologists. As preparation for a talk to opticians on "communication," we arranged a necessarily simple research project. We tested the hypothesis that, at least for patients found by opticians to have raised intraocular pressure, direct referral from optician to ophthalmologist might be better for the patient and would be acceptable to general practitioners-despite infringement of the principle of general-practitioner responsibility for all referral decisions on behalf of his patients.
Methods and results
The records of 100 consecutive new patients seen at an ophthalmology outpatient clinic after referral on form OSC 1Z were reviewed. Copies of five representative OSC IZ forms (with all identifying details obscured) were then sent to 50 general practitioners selected at random. The doctors were asked for their views on several matters relating to referral in general and in relation to the enclosed selection.
Referrals-In the series of 100 patients attending the clinic, the final diagnosis was cataract in 28 patients, glaucoma or possible glaucoma in 18 (62% of the 29 patients in whom opticians suspected the diagnosis), and senile macular degeneration in 10. Other disorders (ranging from physiological cupping to retinal vein thrombosis) were noted in 28 patients and no abnormality reported in 16. Although the delay caused by referral from the optician to the general practitioner was normally less than two weeks, it was between two weeks and eight weeks in 12 cases and over two months in four cases: for one patient in six with suspected glaucoma, the delay exceeded two weeks. Due to hospital waiting lists the waiting time from general practitioner to ophthalmologist averaged a further six weeks but this was normally less for patients with raised intraocular pressure. In 43 cases the general practitioner passed on the OSC 1Z without adding further information.
General practitioner questionnaire-Forty-five of the 50 doctors replied to the questionnaire and one further had retired. Thirty-nine of the 45 respondents estimated they referred on to ophthalmologists 70% or more of patients about whom they received an OSC 1Z. Two of the specimen OSC 1Z forms related to patients with raised intraocular pressure. All 45 doctors would have referred a 48-year-old with pressures of 35 mm in each eye (who did not have glaucoma) and 44 of 45 would have referred a 71-year-old with pressures of 25 and 27 mm (who did have glaucoma). Thirty-nine of 45 agreed that the optician should be able to refer direct to ophthalmologists for suspected glaucoma (with the general practitioner receiving a copy letter) and 31 of 45 expressed the view that direct referral for some further abnormalities would be acceptable.
Comment
The principle that referral to consultants should be through the general practitioner is good and should be breached only for good reason. Precedents are available: dentists refer directly to oral surgeons, and, of course, accident and emergency services often allow patients direct access to specialist services.
The modern ophthalmic optician sees his patients in excellent conditions and with increasingly -sophisticated instrumentation available. When he feels anxious about a patient, and particularly when he finds raised intraocular pressure, few general practitioners will wish to delay referring the patient to an ophthalmologist. It seems logical to re-examine the present policy of referral. Opticians, general practitioners, and ophthalmologists will probably all want such discussions to reflect local traditions and services but probably a national agreement between representatives of the three groups will need to be a preliminary stage.
In the end the two issues that must take priority are that patients are seen by the most appropriate professionals with the least delay and that all clinical information relating to individual patients is efficiently co-ordinated. Our findings suggest the time may be right for some re-adjustment of the present policies relating to ophthalmic illnesses.
We thank Professor C I Phillips and the consultants at the Princess Alexandra Eye Pavilion for access to their records and the many general practitioners who replied to our questionnaire. 
Osteoporosis and calcitonin deficiency
Generalised osteoporosis in young people is often secondary to an endocrine disorder such as thyroid or adrenal hypersecretion or a connective tissue disorder such as osteogenesis imperfecta. Juvenile osteoporosis is a distinct entity that develops in childhood and usually resolves spontaneously. We describe a patient who developed severe osteoporosis after puberty; he was found to have calcitonin deficiency, which may have been causally related to his bone disease.
Case report
A 19-year-old man presented with a three-year history of pain in his feet, knees, and spine together with progressive loss in height of 10 cm. For the previous 12 months he had been incapacitated by his pain. At the age of 16 he had fractured his right ankle and wrist in a motorcycle accident. A further motorcycle accident at the age of 18 had resulted in fractures of the right ankle and tibia. Normal puberty had been achieved from age 14 to 16 years. There was no history of drug or alcohol abuse and no relevant family history.
Clinical examination showed dorsal kyphosis with tenderness over the lower dorsal and lumbar spines. Height was 172 cm, span 181 cm, and weight 56-7 kg. There were no other clinical abnormalities. Investigations (table) showed normal renal, hepatic, pituitary, thyroid, adrenal, and gonadal function. Haematological variables were normal, and sex chromosome karyotype was normal XY. Radiological studies showed generalised osteoporosis with multiple biconcave wedged vertebral bodies. Biopsy of the iliac crest after tetracycline double labelling showed severe osteoporosis with low trabecular bone volume, thin and abnormally porous cortices, and a high remodelling rate. The ratio of type III to type I skin collagens was normal. The only abnormal laboratory findings were a slightly increased urine hydroxyproline excretion and an undetectable circulating calcitonin concentration, which did not rise in response to stimulation with oral alcohol (50 ml 40% w/v ethanol), intravenous pentagastrin (0 5 jig/kg body weight as bolus), or intravenous calcium (50 ,umol (2 mg)/kg body weight over one minute). Other members of his family had normal calcitonin secretion. 
Comment
Calcitonin acts direct on bone to inhibit bone resorption by reducing the activity and number of osteoclasts. The physiological function of the hormone in man is thought to be that of long-term skeletal maintenance, especially when concentrations of bone-resorbing hormones are raised.' In women calcitonin secretion is to some extent oestrogen dependent, and postmenopausal calcitonin deficiency may sensitise the skeleton to the actions of bone-resorbing hormones.2 Furthermore, there is evidence of decreased calcitonin secretion in postmenopausal women with osteoporosis.3 In this patient a deficiency of calcitonin might have allowed the bone-resorbing hormones 1,25-dihydroxy vitamlin D and parathyroid hormone to act on bone unopposed. A dramatic effect on the skeleton would not be expected unless concentrations of bone-resorbing hormones became increased. 1,25-Dihydroxy vitamin D concentrations, however, may be raised during the peripubertal growth spurt4; increased bone resorption could thus take place at this time and the skeletal consequences would become apparent in ensuing years.
Total thyroidectomy is apparently not associated with skeletal problems, although no prospective studies directly assessing bone mass have been carried out. Animal studies have shown extrathyroidal sites of calcitonin production,5 and thus patients who have undergone thyroidectomy do not necessarily lack calcitonin.
We consider that the calcitonin deficiency in this patient may have been causally related to his osteoporosis. Some symptomatic and histological improvement subsequently occurred with calcitonin treatment, although any major benefit is likely to be seen only in the long term. Calcitonin deficiency should be considered in young patients with osteoporosis in whom other causes have been excluded. 
